Mode
Text Size
Log in / Sign up
N/A N=38,933

Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up

Colorectal Cancer

Enrolled (actual)
38,933
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: CRC Screening Rate — 8611; 3989; 9438; 3186 Participants

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Intervention Phase 1: Provider and Staff education (Behavioral); Intervention Phase 2: Provider and staff education + Patient reminder (Behavioral); Intervention Phase 3: Provider and Staff education + Patient reminder + Patient navigation (Behavioral)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
Milton S. Hershey Medical Center
Primary completion
Dec 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
CRC Screening Rate
8611; 3989; 9438; 3186; 10720; 3303
PRIMARY
CRC Screening Ordering Rate
7012; 5087; 6458; 4757; 6478; 4611
PRIMARY
CRC Screening Completion Rate
3106; 1917; 3031; 1749; 3278; 1691
SECONDARY
Provider Education Participation
129; 44; 126; 89
SECONDARY
Patient Reminder Enrollment
4756; 4693; 5198; 3943
SECONDARY
Impact of Remote Patient Navigation Services
529; 284

Summary

Screening for colorectal cancer (CRC) not only detects disease early when treatment is more effective but also prevents cancer by finding and removing precancerous polyps. Because many of our nation's most disadvantaged and vulnerable individuals obtain health care at federally qualified health centers, these centers play a significant role in increasing CRC screenings among the most vulnerable populations. Furthermore, the full benefits of cancer screenings must include timely and appropriate follow-up of abnormal results. Thus, the purpose of this study is to implement a multilevel intervention to increase rates of CRC screenings, follow-ups, and referrals-to-care in federally qualified health centers (FQHCs). Also, we will examine the implementation strategies used to support the implementation process and their contribution to the adoption, implementation, and sustainment of the multilevel intervention. The multilevel intervention will target three different levels of influences: organization, provider, and individual. It will have multiple components, including provider and staff education, provider reminder, provider assessment and feedback, patient reminder, and patient navigation. This study is a multilevel, three-phase, stepped wedge cluster randomized trial with four clusters of clinics from four different FQHCs. Our FQHC partners together have 40 primary care clinics and 130 primary care providers. During Phase 1, there will be a 3-month waiting period during which no intervention components will be implemented. After the 3-month waiting period, we will randomize two clusters of clinics to cross from the control to the intervention and the remaining two clusters to follow three months later. All clusters of clinics will stay at the same phase for nine months, followed by a 3-month transition period, and then cross over to the next phase. In Phase 1, we will implement provider and staff education sessions. In Phase 2, we will add provider reminders, patient reminders, and provider assessment and feedback. We will add patient navigation during the last phase. Single level interventions are often insufficient at leading to sustainable changes. Multilevel interventions are needed to address multilevel contextual influences simultaneously. How to take advantage of multilevel interventions and how to implement such interventions and evaluate their effectiveness are the ultimate goals of this study.

Eligibility Criteria

Eligibility for Federally Qualified Health Centers (FQHCs)

Inclusion criteria

  • Located in Illinois or Indiana
  • Provide adult primary care
  • Serve patients between the ages of 50 and 75 years
  • Able to provide patient-level data

Exclusion criteria

  • Located outside Illinois or Indiana
  • Do not provide adult primary care
  • Unable to provide patient-level data

Eligibility for patients whom our FQHC partners serve:

Inclusion criteria

  • Between the ages of 50 and 75
  • At general risk for colorectal cancer

Exclusion criteria

  • Patients who are younger than 45 years old or older than 75 years old
  • Patients who are at high risk for colorectal cancer screening and require early screening before the age of 45
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04514341). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search